SIPAI HEALTH (00314) spent HK$78,300 on September 4 to repurchase 50,000 shares.
SIPAI Health (00314) announced that on September 4, 2026, it spent HKD 78,300 to repurchase 50,000 shares; according to the revised and restated 2017 Global Share Plan, 2,200 shares were issued as a result of the exercise period being exercised.
SIPAI HEALTH (00314) announced that on September 4, 2026, it spent HKD 78,300 to repurchase 50,000 shares; according to the revised and restated 2017 Global Share Plan, 2,200 shares were issued upon exercise of the options.
Related Articles
Jiangsu Sihuan Bioengineering (000518.SZ) plans to acquire 65.6146% of Zhongrun Pharmaceutical for 160 million yuan.
CHICMAX (02145) invested HK$9.243 million to repurchase 420,000 shares on September 4.
New Stock News | Gebro plans Hong Kong IPO. The China Securities Regulatory Commission requires supplementary explanations regarding the progress of the state-owned shareholder's compliance with state asset management procedures and other matters.
Jiangsu Sihuan Bioengineering (000518.SZ) plans to acquire 65.6146% of Zhongrun Pharmaceutical for 160 million yuan.
CHICMAX (02145) invested HK$9.243 million to repurchase 420,000 shares on September 4.
New Stock News | Gebro plans Hong Kong IPO. The China Securities Regulatory Commission requires supplementary explanations regarding the progress of the state-owned shareholder's compliance with state asset management procedures and other matters.
RECOMMEND
